Who has invested in Maiva Pharma?

Morgan Stanley Private Equity Asia, India Life Sciences Fund-IV are named among the investors backing Maiva Pharma.

Maiva Pharma Funding: $124M Raised, Series D (2024)

Maiva Pharma funding overview

Maiva Pharma is based in Bangalore, Karnataka, India. Maiva Pharma has raised $124M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in May 2024. The round record for Maiva Pharma runs through 2024; nothing later has been disclosed. Investors on record include Morgan Stanley Private Equity Asia, India Life Sciences Fund-IV. 2 distinct backers are named across the disclosed rounds.

Maiva Pharma at a glance

Total raised: $124M
Latest round: Series D
Latest round date: May 2024
Headquarters: Bangalore, Karnataka, India
Notable investors: Morgan Stanley Private Equity Asia, India Life Sciences Fund-IV

Frequently asked about Maiva Pharma funding

How much has Maiva Pharma raised?: Maiva Pharma has raised $124M in total disclosed funding across the rounds on record.
Who has invested in Maiva Pharma?: Morgan Stanley Private Equity Asia, India Life Sciences Fund-IV are named among the investors backing Maiva Pharma.
What was the latest Maiva Pharma funding round?: The most recent disclosed round is a Series D, announced in May 2024.
Where is Maiva Pharma based?: Maiva Pharma is based in Bangalore, Karnataka, India.
When did Maiva Pharma last raise?: The last disclosed Maiva Pharma round closed in May 2024 at Series D.

Totals shown for Maiva Pharma aggregate every disclosed round on file. To see how that compares, browse the companies in Bangalore and the investors behind them below.

Maiva Pharma Funding: $124M Raised, Series D (2024)

Maiva Pharma funding overview

Maiva Pharma at a glance

Frequently asked about Maiva Pharma funding

Companies related to Maiva Pharma (20)

Browse related funding lists (3)